Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Apr;26(4):338-340.
doi: 10.1097/GME.0000000000001313.

Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy

Andrew M Kaunitz  1 , JoAnn V Pinkerton  2 , JoAnn E Manson  3
Affiliations
Comment

Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy

Andrew M Kaunitz et al. Menopause. 2019 Apr.

Abstract

Genitourinary syndrome of menopause (GSM) represents a highly prevalent condition in menopausal women which impairs quality of life. Unless treated, GSM is chronic and progressive.

PubMed Disclaimer

Conflict of interest statement

Financial disclosures/conflicts of interest: AMK: Consults with AMAG and Pfizer; Research funding (to University of Florida) from Endoceutics, TherapeuticsMD. The other authors have nothing to disclose.

Comment on

References

    1. Pinkerton JV. North American Menopause Society. FDA mandating vaginal laser manufacturers presents valid data before marketing August 1, 2018. https://www.menopause.org/docs/default-source/default-document-library/n... Accessed January 11, 2019.
    1. FDA Warns Against Use of Energy-Based devices to perform vaginal ‘rejuvenation’ or vaginal cosmetic procedures: FDA Safety Communication. July 30, 2018. (Updated November 20, 2018). https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm615013.htm Accessed January 11, 2019.
    1. Mitchell CM, Reed SD, Diam S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: A randomized clinical trial. JAMA Intern Med 2018; 178:681–690. - PMC - PubMed
    1. Shifren JL. Genitourinary syndrome of menopause. Clin Obstet Gynecol 2018; 61: 508–516. - PubMed
    1. Pinkerton JV, Kaunitz AM, Manson JE. Not time to abandon use of local vaginal hormone therapies. Menopause 2018; 25: 855–858. - PubMed